Micha Levy
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions 5
- Geriatrics and Gerontology top 1%
- Nephrology top 1%
- Gout, Hyperuricemia, Uric Acid 5
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects 5
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 4
-
- Inflammasome and immune disorders 11
-
- Blood disorders and treatments 8
-
- Neonatal Health and Biochemistry 4
- Pharmaceutical studies and practices 4
- Co-authors
- Eldad Ben‐ChetritEster Zylber‐KatzM EliakimYoseph CaracoBernd RosenkranzDennis E. DrayerMarcus M. ReidenbergSamuel Shapiro
- Journals
- Clinical Pharmacology & Therapeutics (7 papers)The American Journal of the Medical Sciences (3 papers)Seminars in Arthritis and Rheumatism (3 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Micha Levy
49 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Toxicology 276
- Geriatrics and Gerontology 256
- Nephrology 461
- Pharmacology 283
- Immunology 647
Countries citing papers authored by Micha Levy
This map shows the geographic impact of Micha Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micha Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micha Levy more than expected).
Fields of papers citing papers by Micha Levy
This network shows the impact of papers produced by Micha Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micha Levy. The network helps show where Micha Levy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Micha Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 32 | |
| 2 | 2005 | 34 | |
| 3 | 2004 | 19 | |
| 4 | 2003 | 66 | |
| 5 | 2001 | 6 | |
| 6 | 2000 | 142 | |
| 7 | 1998 | 259 | |
| 8 | Familial Mediterranean feverbreakdown → | 1998 | 547 |
| 9 | 1998 | 13 | |
| 10 | 1998 | 55 | |
| 11 | 1997 | 48 | |
| 12 | 1996 | 27 | |
| 13 | 1995 | 15 | |
| 14 | 1992 | 32 | |
| 15 | 1991 | 111 | |
| 16 | 1991 | 122 | |
| 17 | 1990 | 8 | |
| 18 | 1989 | 14 | |
| 19 | 1988 | 78 | |
| 20 | 1978 | 41 |
About Micha Levy
Micha Levy is a scholar working on Toxicology, Pharmacology, Geriatrics and Gerontology, Nephrology and Pharmacology, having authored 51 papers that have together received 3.5k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (11 papers), Blood disorders and treatments (8 papers), Inflammatory mediators and NSAID effects (5 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers), Neonatal Health and Biochemistry (4 papers), Pharmaceutical studies and practices (4 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). The work is most often cited by research in Toxicology (276 citations), Geriatrics and Gerontology (256 citations), Nephrology (461 citations), Pharmacology (283 citations) and Immunology (647 citations). Micha Levy has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Eldad Ben‐Chetrit, Ester Zylber‐Katz, M Eliakim, Yoseph Caraco, Bernd Rosenkranz, Dennis E. Drayer, Marcus M. Reidenberg, Samuel Shapiro, David W. Kaufman and L. Granit. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The American Journal of the Medical Sciences, Seminars in Arthritis and Rheumatism, Drug Safety and European Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.